Nuance Investments LLC Reduces Stake in Globe Life Inc. $GL

Nuance Investments LLC decreased its holdings in Globe Life Inc. (NYSE:GL) by 54.5% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 260,218 shares of the company’s stock after selling 311,349 shares during the period. Globe Life comprises approximately 3.8% of Nuance Investments LLC’s investment portfolio, making the stock its 10th biggest holding. Nuance Investments LLC owned about 0.32% of Globe Life worth $37,203,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of GL. Candriam S.C.A. increased its position in shares of Globe Life by 25.3% in the 3rd quarter. Candriam S.C.A. now owns 181,435 shares of the company’s stock valued at $25,940,000 after acquiring an additional 36,646 shares during the period. Smartleaf Asset Management LLC lifted its holdings in shares of Globe Life by 19.7% in the 3rd quarter. Smartleaf Asset Management LLC now owns 2,513 shares of the company’s stock valued at $361,000 after buying an additional 413 shares during the period. Canada Post Corp Registered Pension Plan boosted its position in Globe Life by 44.4% in the 3rd quarter. Canada Post Corp Registered Pension Plan now owns 1,560 shares of the company’s stock worth $224,000 after purchasing an additional 480 shares in the last quarter. Castlekeep Investment Advisors LLC grew its stake in shares of Globe Life by 25.1% during the 3rd quarter. Castlekeep Investment Advisors LLC now owns 13,604 shares of the company’s stock worth $1,945,000 after purchasing an additional 2,733 shares during the period. Finally, Savant Capital LLC lifted its stake in shares of Globe Life by 3.6% in the 3rd quarter. Savant Capital LLC now owns 69,864 shares of the company’s stock valued at $9,988,000 after purchasing an additional 2,402 shares during the period. Institutional investors own 81.61% of the company’s stock.

Globe Life Price Performance

Shares of NYSE GL opened at $146.62 on Monday. The company’s 50-day moving average price is $139.38 and its 200 day moving average price is $138.17. The stock has a market cap of $11.67 billion, a price-to-earnings ratio of 10.41 and a beta of 0.47. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life Inc. has a 52 week low of $109.38 and a 52 week high of $152.71.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The company had revenue of $1.52 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter in the prior year, the company earned $3.14 earnings per share. The firm’s revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, research analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Frank M. Svoboda sold 9,379 shares of the firm’s stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $140.43, for a total value of $1,317,092.97. Following the transaction, the chief executive officer directly owned 35,868 shares in the company, valued at $5,036,943.24. This trade represents a 20.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.51% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have weighed in on GL. Piper Sandler reiterated an “overweight” rating and issued a $167.00 price objective on shares of Globe Life in a research report on Friday, November 21st. Weiss Ratings cut Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, January 14th. TD Cowen reissued a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. JPMorgan Chase & Co. boosted their price objective on Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday. Finally, Truist Financial upped their target price on Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research note on Friday. Seven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $171.00.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.